UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): January 11, 2006 (January 11, 2006)
Endo
Pharmaceuticals Holdings Inc.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| Delaware
|
|
001-15989
|
|
13-4022871 |
| |
|
|
|
|
|
|
| (State or other jurisdiction
|
|
(Commission
|
|
(I.R.S. Employer |
| of incorporation)
|
|
File Number)
|
|
Identification No.) |
| |
|
|
|
|
| 100 Endo Boulevard, Chadds Ford, PA
|
|
|
|
19317 |
| |
|
|
|
|
|
|
| (Address of principal executive offices)
|
|
|
|
(Zip Code) |
Registrant’s telephone number, including area code (610) 558-9800
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
TABLE OF CONTENTS
Item 7.01. Regulation FD Disclosure.
On January 11, 2006, the Registrant intends to make a slide presentation at the JP Morgan
Healthcare Conference in San Francisco California, a copy of which presentation is filed herewith
as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
| (a) |
|
Financial Statements of Business Acquired. |
Not applicable.
| (b) |
|
Pro Forma Financial Information. |
Not applicable.
| |
|
|
| Exhibit Number |
|
Description |
|
|
|
99.1
|
|
Slide Presentation of Endo Pharmaceuticals Holdings Inc. dated January 11, 2006 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused
this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| |
|
|
|
|
|
|
|
|
| |
|
ENDO PHARMACEUTICALS HOLDINGS INC. |
|
|
|
|
|
|
(Registrant) |
|
|
|
|
|
|
|
|
|
|
|
| |
|
By: |
|
/s/ Caroline B. Manogue |
|
|
| |
|
|
|
|
|
|
|
|
|
|
Name:
|
|
Caroline B. Manogue |
|
|
| |
|
|
|
Title: |
|
Executive Vice President, Chief Legal Officer & |
|
|
|
|
|
|
Secretary |
|
|
Dated: January 11, 2006